Követés
Beáta Biri-Kovács
Beáta Biri-Kovács
National Institute of Oncology, Budapest, Hungary
E-mail megerősítve itt: oncol.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
The growth determinants and transport properties of tunneling nanotube networks between B lymphocytes
A Osteikoetxea-Molnár, E Szabó-Meleg, EA Tóth, Á Oszvald, E Izsépi, ...
Cellular and Molecular Life Sciences 73, 4531-4545, 2016
572016
Body fatness and endogenous sex hormones in the menopausal transition
A Zsakai, Z Karkus, K Utczas, B Biri, LL Sievert, EB Bodzsar
Maturitas 87, 18-26, 2016
342016
Dynamic control of RSK complexes by phosphoswitch‐based regulation
G Gógl, B Biri‐Kovács, ÁL Póti, H Vadászi, B Szeder, A Bodor, ...
The FEBS journal 285 (1), 46-71, 2018
312018
Enhanced in vitro antitumor activity of GnRH-III-daunorubicin bioconjugates influenced by sequence modification
S Schuster, B Biri-Kovács, B Szeder, L Buday, J Gardi, Z Szabó, ...
Pharmaceutics 10 (4), 223, 2018
282018
Rewiring of RSK–PDZ interactome by linear motif phosphorylation
G Gógl, B Biri-Kovács, F Durbesson, P Jane, Y Nomine, C Kostmann, ...
Journal of molecular biology 431 (6), 1234-1249, 2019
272019
Cellular internalization and inhibition capacity of new anti-glioma peptide conjugates: physicochemical characterization and evaluation on various monolayer-and 3D-spheroid …
Z Baranyai, B Biri-Kovács, M Kratky, B Szeder, ML Debreczeni, J Budai, ...
Journal of medicinal chemistry 64 (6), 2982-3005, 2021
262021
Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery
S Schuster, B Biri-Kovács, B Szeder, V Farkas, L Buday, Z Szabó, ...
Beilstein Journal of Organic Chemistry 14 (1), 756-771, 2018
242018
Ezrin interacts with S100A4 via both its N-and C-terminal domains
B Biri-Kovács, B Kiss, H Vadászi, G Gógl, G Pálfy, G Török, L Homolya, ...
PloS one 12 (5), e0177489, 2017
242017
In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery
AAP Tripodi, I Ranđelović, B Biri-Kovács, B Szeder, G Mező, J Tóvári
Pathology & Oncology Research 26, 1879-1892, 2020
232020
Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems
K Kiss, B Biri-Kovács, R Szabó, I Ranđelović, KN Enyedi, G Schlosser, ...
European Journal of Medicinal Chemistry 176, 105-116, 2019
202019
Metastasis-associated S100A4 is a specific amine donor and an activity-independent binding partner of transglutaminase-2
B Biri, B Kiss, R Király, G Schlosser, O Láng, L Kőhidai, L Fésüs, L Nyitray
Biochemical Journal 473 (1), 31-42, 2016
192016
Structure–activity relationship of HER2 receptor targeting peptide and its derivatives in targeted tumor therapy
B Biri-Kovács, A Adorján, I Szabó, B Szeder, S Bősze, G Mező
Biomolecules 10 (2), 183, 2020
162020
Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog
P Lukacs, MC Földi, L Valánszki, E Casanova, B Biri-Kovács, L Nyitray, ...
Scientific Reports 8 (1), 8110, 2018
152018
Novel Assay Platform to Evaluate Intracellular Killing of Mycobacterium tuberculosis: In Vitro and In Vivo Validation
K Horváti, K Fodor, B Pályi, J Henczkó, G Balka, G Gyulai, É Kiss, ...
Frontiers in Immunology 12, 750496, 2021
142021
Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids
E Lajkó, S Spring, R Hegedüs, B Biri-Kovács, S Ingebrandt, G Mező, ...
Beilstein Journal of Organic Chemistry 14 (1), 2495-2509, 2018
142018
Old polyanionic drug suramin suppresses detrimental cytotoxicity of the host defense peptide LL-37
M Quemé-Peña, M Ricci, T Juhász, K Horváti, S Bősze, B Biri-Kovács, ...
ACS Pharmacology & Translational Science 4 (1), 155-167, 2020
92020
Host cell targeting of novel antimycobacterial 4-aminosalicylic acid derivatives with tuftsin carrier peptides
LB Horváth, M Krátký, V Pflégr, E Méhes, G Gyulai, G Kohut, Á Babiczky, ...
European Journal of Pharmaceutics and Biopharmaceutics 174, 111-130, 2022
82022
Modification of Short Non‐Permeable Peptides to Increase Cellular Uptake and Cytostatic Activity of Their Conjugates
M Yousef, I Szabó, B Biri‐Kovács, B Szeder, F Illien, S Sagan, Z Bánóczi
ChemistrySelect 6 (38), 10111-10120, 2021
82021
A Convenient Synthetic Method to Improve Immunogenicity of Mycobacterium tuberculosis Related T-Cell Epitope Peptides
K Horvati, B Pályi, J Henczko, G Balka, E Szabo, V Farkas, B Biri-Kovacs, ...
Vaccines 7 (3), 101, 2019
82019
Targeting the gastrin-releasing peptide receptor (GRP-R) in cancer therapy: Development of bombesin-based peptide–drug conjugates
J Gomena, B Vári, R Oláh-Szabó, B Biri-Kovács, S Bősze, A Borbély, ...
International Journal of Molecular Sciences 24 (4), 3400, 2023
72023
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20